(1S,7S)-5,9-Dimethyltricyclo[5.2.1.02,6]dec-4-en-8-ol
Common Name: |
(1S,7S)-5,9-Dimethyltricyclo[5.2.1.02,6]dec-4-en-8-ol |
IUPAC Name: |
(1S,7S)-5,9-dimethyltricyclo[5.2.1.02,6]dec-4-en-8-ol |
Molecular Formula: |
C12H18O |
SMILES: |
CC1C2CC(C1O)C3C2CC=C3C |
Inchi: |
1S/C12H18O/c1-6-3-4-8-9-5-10(11(6)8)12(13)7(9)2/h3,7-13H,4-5H2,1-2H3/t7?,8?,9-,10+,11?,12?/m1/s1 |
Inchi Key: |
JPUCFBUQBMPIGY-FHXMXALBSA-N |
Cas No: |
94248-21-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
178.27 |
Mass (g/mol) |
178.136 |
Molar Refractivity |
54.14 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
0 |
Rings |
3 |
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.83 |
LogP |
2.216 |
iLOGP |
2.62 |
XLOGP3 |
1.94 |
WLOGP |
2.22 |
MLOGP |
2.88 |
ESOL Log S |
-2.17 |
ESOL Solubility (mg/ml) |
1.21 |
ESOL Solubility (mol/l) |
0.007 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-1.99 |
Ali Solubility (mg/ml) |
1.83 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.21 |
Silicos-IT Solubility (mg/ml) |
10.9 |
Silicos-IT Solubility (mol/l) |
0.06 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.01 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.083 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.147 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |